Details for 2021802088

Up to date per 04.04.2026

Actions

Title / Product Name

VERFAHREN ZUR RACEMISIERUNG UND ISOLIERUNG VON ATROPISOMEREN VON 7-CHLOR-6-FLUOR-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D!PYRIMIDIN-2,4(1H,3H)-DION

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021802088

EP Publication Number

4225755

E-Number

1881142

Language

PCT Number

US21053859

Publication Date

16.08.2023 A

28.01.2026 B1

Registration Date

28.01.2026

AT Publication Date

15.02.2026

Application Date

06.10.2021

Registration Number

Priorities

07.10.2020

202063088848 P

17.03.2021

202163162278 P

IPC

C07D 471/04 20060101AFI20220415BHEP

Maximum Duration of Protection

06.10.2041

Owner

Amgen Inc.1 Amgen Center Drive Thousand Oaks, California 91320-1799US

Representative

No representatives present

Inventor

BEAVER, Matthew G. Thousand Oaks, CA 91320-1799US

CORBETT, Michael T. Thousand Oaks, CA 91320-1799US

FANG, Yuanqing Waltham, Massachusetts 02451US

FORD, David D. Waltham, Massachusetts 02451US

PARSONS, Andrew T. Thousand Oaks, CA 91320-1799US

ST-PIERRE, Gabrielle Thousand Oaks, CA 91320-1799US

TELMESANI, Reem Waltham, Massachusetts 02451US

Information about Fees